Menarini strengthens its presence in aesthetic dermatology in India
The introduction of 'Definisse Core Filler' is a testament to the company's premium scientific-based innovation
The introduction of 'Definisse Core Filler' is a testament to the company's premium scientific-based innovation
Capital raise to accelerate product and technology development and support expansion efforts to reshape communications to HCPs across the globe
Glenmark will receive from Cassiopea, a subsidiary of Cosmo, the exclusive right to commercialize Winlevi in 15 EU countries
The AGE1.CR.pIX cell line's versatility allows it to support a wide range of viruses and vaccine types
The investment will help the company meet soaring demand for user-friendly oral dosage form development and manufacturing
Kivo’s expanded platform brings compliant collaboration and intelligent process automation to emerging Regulatory, Clinical and Quality teams
Commenced operations in flood-affected Himachal Pradesh
Biosergen AB is developing BSG005 for the treatment of severe and difficult-to-treat invasive fungal diseases
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD)
Subscribe To Our Newsletter & Stay Updated